Prognostic value of the baseline triglyceride-glucose-body mass index in small cell lung cancer undergoing chemoimmunotherapy: A multicenter retrospective study

Key Points

• Higher baseline triglyceride levels correlate with decreased survival in small cell lung cancer patients undergoing treatment.
• Significant associations found with baseline biomarkers, specifically triglycerides and body mass index, in 120 patients.
• Retrospective analysis of multicenter data highlights the role of triglycerides and glucose in breast cancer outcomes.
• Findings suggest potential for using baseline triglyceride-glucose-body mass index to guide treatment decisions.